688687 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Beijing Kawin Technology Share-Holding Co., Ltd. research, development, production and sales of drugs in the field of viral diseases. Its products include compound glycyrrhizin capsules, vaginal effervescent tablets, omeprazole sodium for injection, liraglutide, nivolumab, and filgrastim. The company was founded on August 20, 2008 and is headquartered in Beijing, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
688687 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company